Skip to main content

Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017

| News

Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017


In April, Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products opened a facility in Basel, Switzerland. The new site will serve as a European headquarters for the company with administration offices and other areas that include research and development, purchasing, sales, and distribution. Bio-Rad was founded in 1952 and is based in Hercules, California, and has offices and facilities around the world. In 2017, embarking on its 65th year of operation, Bio-Rad’s global network of over 8,250 employees and operations are helping people live longer, healthier lives.

(img: Bio-Rad)

The California-based company is joining a growing number of US biotech companies such as Ultragenyx, Roivant Sciences and Singulex that have recently opened their European and global headquarters in Basel, Switzerland.

Bio-Rad is among the top five life science companies in the world, providing instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. The company’s products and solutions are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.

As a leading global provider of in-vitro diagnostics supplies, Bio-Rad’s diagnostic products and systems leverage a broad range of technologies and deliver high-value clinical information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets. These products are used to support the diagnosis, monitoring, and treatment of diseases and other medical conditions.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.